For decades , clinicians have sought effective solutions for treatment-resistant depressive illness . Now points to this novel drug therapy, given typically intravenously , may offer considerable advance for people who haven't benefited from standard therapies. While largely considered a developing treatment , initial findings are showing remarkabl